γ-Aminobutyric Acid-Type A Receptor Deficits Cause Hypothalamic-Pituitary-Adrenal Axis Hyperactivity and Antidepressant Drug Sensitivity Reminiscent of Melancholic Forms of Depression-Reference-Cited by-同舟云学术

γ-Aminobutyric Acid-Type A Receptor Deficits Cause Hypothalamic-Pituitary-Adrenal Axis Hyperactivity and Antidepressant Drug Sensitivity Reminiscent of Melancholic Forms of Depression

Published:2010-09 Issue:6 Volume:68 Page:512-520
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Shen Qiuying,Lal Rachnanjali,Luellen Beth A.,Earnheart John C.,Andrews Anne Milasincic,Luscher Bernhard

Funder

National Institutes of Mental Health

Pennsylvania Department of Health

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference70 articles.

1. Major depression and generalised anxiety disorder;Kendler;Br J Psychiatry Suppl,1996

2. A twin study of anxiety-related behaviours in pre-school children;Eley;J Child Psychol Psychiatry,2003

3. Comorbidity of mood and anxiety disorders;Kaufman;Depress Anxiety,2000

4. Anxiety and depression: A 40-year perspective on relationships regarding prevalence, distribution, and comorbidity;Murphy;Acta Psychiatr Scand,2004

5. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report;Fava;Am J Psychiatry,2008

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex-specific GABAergic microcircuits that switch vulnerability into resilience to stress and reverse the effects of chronic stress exposure;2024-07-11

2. Transcriptome signatures of the medial prefrontal cortex underlying GABAergic control of resilience to chronic stress exposure;2024-07-10

3. Sex-specific GABAergic microcircuits that switch vulnerability into resilience to stress and reverse the effects of chronic stress exposure;2024-07-09

4. Promising new pharmacological targets for depression: The search for efficacy;Drug Discovery Today;2023-12

5. GABAA receptors as targets for treating affective and cognitive symptoms of depression;Trends in Pharmacological Sciences;2023-09